Related Experiment Video
Updated: Jul 11, 2026
06:36
Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
THE IN VITRO PROTECTION OF PENICILLIN FROM INACTIVATION BY PENICILLINASE
Science (New York, N.Y.)
|August 17, 1945
Summary
A novel combination of penicillin and immune plasma protein exhibits bacteriostatic activity. This immune plasma protein also protects penicillin from degradation by penicillinase in laboratory settings.
Area of Science:
- Microbiology
- Immunology
- Pharmacology
Background:
- Penicillin is a widely used antibiotic, but its efficacy can be limited by bacterial resistance mechanisms.
- Penicillinase is an enzyme produced by some bacteria that inactivates penicillin.
- Immune plasma proteins offer potential therapeutic applications, including antimicrobial support.
Purpose of the Study:
- To develop a combination therapy with bacteriostatic activity.
- To investigate the protective effect of immune plasma protein against penicillinase.
- To evaluate the in vitro stability of penicillin in the presence of penicillinase and immune plasma protein.
Main Methods:
- Preparation of a combination of penicillin and immune plasma protein.
- In vitro assessment of the bacteriostatic activity of the combination.
- In vitro evaluation of penicillin stability in the presence of penicillinase and immune plasma protein.
Main Results:
- The combined penicillin and immune plasma protein preparation demonstrated significant bacteriostatic activity.
- Immune plasma protein effectively protected penicillin from inactivation by penicillinase in vitro.
- The combination maintained penicillin's integrity against enzymatic degradation.
Conclusions:
- The combination of penicillin and immune plasma protein presents a promising approach for enhanced antimicrobial therapy.
- Immune plasma protein can serve as a protective agent for penicillin against penicillinase, potentially overcoming resistance mechanisms.
- This combination warrants further investigation for clinical applications in treating bacterial infections.
More Related Videos
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...